Correspondingly, it showed that CD101 expression could potentially interact with numerous immune-relevant genes, including CD276, CD274, CD80, CTLA4, and PDCD1, implying an immunoregulatory role of CD101 in the glioma immune microenvironment (Figure 9). The gene discussed is CD101; the disease is central nervous system cancer.